The African cancer burden: what is the potential role of modern oncology innovation in reducing the continent's rapidly rising mortality?


Journal

Postgraduate medical journal
ISSN: 1469-0756
Titre abrégé: Postgrad Med J
Pays: England
ID NLM: 0234135

Informations de publication

Date de publication:
22 Aug 2023
Historique:
received: 10 10 2022
accepted: 28 04 2023
medline: 23 8 2023
pubmed: 7 6 2023
entrez: 6 6 2023
Statut: ppublish

Résumé

With increasing prevalence and an expected rise in disease burden, cancer is a cause of concern for African healthcare. The cancer burden in Africa is expected to rise to 2.1 million new cases per year and 1.4 million deaths annually by the year 2040. Even though efforts are being made to improve the standard of oncology service delivery in Africa, the current state of cancer care is not yet on par with the rise in the cancer burden. Cutting-edge technologies and innovations are being developed across the globe to augment the battle against cancer; however, many of them are beyond the reach of African countries. Modern oncology innovations targeted to ward Africa would be promising to address the high cancer mortality rates. The innovations should be cost-effective and widely accessible to tackle the rapidly rising mortality rate on the African continent. Though it may seem promising, a multidisciplinary approach is required to overcome the challenges associated with the development and implementation of modern oncology innovations in Africa.

Identifiants

pubmed: 37280156
pii: 7191006
doi: 10.1093/postmj/qgad043
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

941-945

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Postgraduate Medical Journal. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Wireko Andrew Awuah (WA)

Faculty of Medicine, Sumy State University, Sumy 40007, Ukraine.

Jyi Cheng Ng (JC)

Faculty of Medicine and Health Sciences, University of Putra Malaysia, Serdang 43400, Malaysia.

Aashna Mehta (A)

Faculty of Medicine, University of Debrecen, Debrecen 4032, Hungary.

Esther Patience Nansubuga (EP)

Faculty of Medicine, University of Leeds, Leeds LS2 9TJ, United Kingdom.

Toufik Abdul-Rahman (T)

Faculty of Medicine, Sumy State University, Sumy 40007, Ukraine.

Mrinmoy Kundu (M)

Faculty of Medicine, Institute of Medical Sciences and SUM Hospital, Bhubaneswar 751029, India.

Brian M Ou Yong (BM)

School of Medicine, College of Medical & Veterinary Life Sciences, University of Glasgow, Glasgow G11 6QQ, United Kingdom.

Jacob Kalmanovich (J)

College of Medicine, Drexel University, Philadelphia, PA 19129, United States.

Aysha Hussain (A)

School of Medicine, Ross University, Bridgetown 33133, Barbados.

Otumara Urowoli Jessica (OU)

Faculty of Medicine, Sumy State University, Sumy 40007, Ukraine.

Karl Kamanousa (K)

College of Medicine, Drexel University, Philadelphia, PA 19129, United States.

Aymar Akilimali (A)

Faculty of Medicine, Official University of Bukavu, Bukavu 57010, DR Congo.

Kateryna Sikora (K)

Faculty of Medicine, Sumy State University, Sumy 40007, Ukraine.

Arda Isik (A)

Department of General Surgery, Istanbul Medeniyet University, Istanbul 34100, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH